No Data
No Data
No Data
Biophytis to Halt Trading Amid Closing of Refinancing Deal
Biophytis Deploys Its Partnership Strategy and Signs Two Contracts With Local Agents in Asia
Biophytis Obtains IND Approval From the FDA to Start Its Phase 2 OBA Study in Obesity
Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris
6-K: Report of foreign private issuer (related to financial reporting)
Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million
comecomecome : Is a bad news?
108S OP : Not a bad news
comecomecome : Have you bought one?
108S OP : Yes
comecomecome 108S OP : Are you still keeping it
View more comments...